Julie Fox

Best Publications

• Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial.

  Sheena McCormack;David T. Dunn;Monica Desai;David I. Dolling

  2193
  Citations

• Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

  Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  1068
  Citations

• Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.

  Cormac Cosgrove;James E. Ussher;Andri Rauch;Kathleen Gärtner

  361
  Citations

• Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.

  J Frater;K J Ewer;A Ogbe;M Pace

  232
  Citations

• Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

  Kathleen B. Yates;Kathleen B. Yates;Pierre Tonnerre;Pierre Tonnerre;Genevieve E. Martin;Genevieve E. Martin;Ulrike Gerdemann

  215
  Citations

• Reductions in HIV transmission risk behaviour following diagnosis of primary HIV infection: a cohort of high-risk men who have sex with men.

  Julie Fox;Peter J White;Peter J White;Neil Macdonald;Jonathan Weber

  206
  Citations

• Effects of hydroxychloroquine on immune activation and disease progression among HIV-infected patients not receiving antiretroviral therapy: a randomized controlled trial.

  Nicholas I. Paton;Ruth L. Goodall;David T. Dunn;Samuel Franzen

  175
  Citations

• Exhaustion of Activated CD8 T Cells Predicts Disease Progression in Primary HIV-1 Infection.

  Matthias Hoffmann;Matthias Hoffmann;Nikos Pantazis;Genevieve E. Martin;Stephen Hickling

  171
  Citations

• Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial

  Jean-Michel Molina;Kathleen Squires;Paul E Sax;Pedro Cahn

  165
  Citations

• Alterations in T and B cell function persist in convalescent COVID-19 patients.

  Halima A Shuwa;Tovah N Shaw;Sean B Knight;Kelly Wemyss

  156
  Citations

• Early intervention with 3BNC117 and romidepsin at antiretroviral treatment initiation in people with HIV-1: a phase 1b/2a, randomized trial

  Unknown

  155
  Citations

• Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa

  Richard Muhumuza;Andrew Sentoogo Ssemata;Ayoub Kakande;Nadia Ahmed

  151
  Citations

• Sexual transmission of HIV-1.

  Julie Fox;Sarah Fidler

  144
  Citations

• Antiretroviral therapy alone versus antiretroviral therapy with a kick and kill approach, on measures of the HIV reservoir in participants with recent HIV infection (the RIVER trial): a phase 2, randomised trial

  S Fidler;W Stöhr;M Pace;L Dorrell

  129
  Citations

• Improvement in vitamin D deficiency following antiretroviral regime change: Results from the MONET trial.

  Julie Fox;Barry Peters;Manyu Prakash;Jose Arribas

  123
  Citations

• Ultrasensitive Detection and Phenotyping of CD4+ T Cells with Optimized HLA Class II Tetramer Staining

  Thomas J. Scriba;Marco Purbhoo;Cheryl L. Day;Nicola Robinson

  112
  Citations

• An overview of the relative risks of different sexual behaviours on HIV transmission.

  Olamide Dosekun;Julie Fox

  103
  Citations

• Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

  Nicholas I Paton;Nicholas I Paton;Wolfgang Stöhr;Alejandro Arenas-Pinto;Martin Fisher

  99
  Citations

• Switching from a ritonavir-boosted protease inhibitor to a dolutegravir-based regimen for maintenance of HIV viral suppression in patients with high cardiovascular risk.

  José M. Gatell;Lambert Assoumou;Graeme Moyle;Laura Waters

  96
  Citations

• BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022

  Unknown

  90
  Citations